The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐Helicobacter pylori quadruple therapies
Open accessAbstract
Summary: Background : Owing to rising drug‐resistant Helicobacter pylori infections, currently recommended proton‐pump inhibitor‐based triple therapies are losing their efficacy, and regimens efficacious in the presence of drug resistance are needed. Aims : To summarize the efficacy, safety and adherence of first‐line quadruple H. pylori therapies in adults. Methods : Meta‐regression models identified factors explaining variation in the efficacy of first‐line quadruple therapies from 145 treatment arms. Estimates of average efficacy were calculated within homogeneous groups. Results : Quadruple therapy containing a gastric acid inhibitor, bismuth, metronidazole and tetracycline was enhanced when omeprazole was included, treatment duration lasted 10–14 days, and when therapy took place in the Netherlands, Hong Kong and Australia. Treatment efficacy decreased as the prevalence of metronidazole resistance increased. Even in areas with a high prevalence of metronidazole resistance, this quadruple regimen eradicated more than 85% of H. pylori infections when it contained omeprazole and was given for 10–14 days. Furthermore, in the presence of clarithromycin resistance, this quadruple regimen eradicated 90–100% of H. pylori infections, while the currently recommended triple therapy containing clarithromycin, amoxicillin and a proton‐pump inhibitor eradicated only 25–61% (P < 0.001). Adherence and adverse events for quadruple therapy were similar to currently recommended triple therapies. Conclusions : Guidelines should include quadruple therapy with a proton‐pump inhibitor, a bismuth compound, metronidazole and tetracycline among recommended first‐line anti‐H. pylori therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Publication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Graham, D. Y., Lew, G. M., Klein, P. D., Evans, D. G., Evans, D. J., Saeed, Z. A., & Malaty, H. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-9-705 · Cited by 909
Invited commentary: a critical look at some popular meta-analytic methods
Greenland, S. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117248 · Cited by 511
Greenland, S. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117250 · Cited by 150
Hosking, S. W., Ling, T. K., Yung, M. Y., Cheng, A., Chung, S. C., Leung, J. W., & Li, A. K. (1992) · BMJ · doi:10.1136/bmj.305.6852.502 · Cited by 117
Cited by
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
Chey, W. D., Wong, B. C. Y., & Practice Parameters Committee of the American College of Gastroenterology (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01393.x · Cited by 1,406
Helicobacter pylori treatment in the era of increasing antibiotic resistance
Graham, D. Y., & Fischbach, L. (2010) · Gut · doi:10.1136/gut.2009.192757 · Cited by 1,028
Self-citationGatta, L., Vakil, N., Leandro, G., Mario, F. D., & Vaira, D. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.555 · Cited by 274
Metadata
- Authors
- Fischbach, L. A., van Zanten, S. V., & Dickason, J.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2004-11
- Volume
- 20
- Issue
- 10
- Pages
- 1071-1082
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2079175995
- Cited by
- 204
- References
- 6
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐Helicobacter pylori quadruple therapies. https://app.cochat.ai/papers/10.1111/j.1365-2036.2004.02248.x
- The paper
- Fischbach, L. A., van Zanten, S. V., & Dickason, J. (2004). Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐Helicobacter pylori quadruple therapies. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2004.02248.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.